Imaging biomarkers refer to specific features or characteristics identified through medical imaging techniques that can indicate the presence, progression, or response to treatment of a disease or condition. These biomarkers can include changes in tissue structure, function, or metabolism that are visible through imaging modalities such as MRI, CT, PET, or ultrasound. By analyzing these imaging biomarkers, researchers and clinicians can better understand disease processes, monitor treatment effectiveness, and personalize treatment approaches for patients. Imaging biomarkers have the potential to improve diagnostic accuracy, predict disease outcomes, and enhance the development of new therapies in various fields such as oncology, neurology, cardiology, and rheumatology.